AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12518497
Drug: Negative control
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative control (20 teeth without Class I preparations)
Trial: 19497245
Drug: Quetiapine (300-450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (300-450 mg/day) plus citalopram (60 mg/day)
Trial: 19497245
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus citalopram (60 mg/day)
Trial: 22171722
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of Straumann implants (SLActive®)
Trial: 22171722
Drug: Early loading
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early loading of Straumann implants (SLActive®)
Trial: 17267740
Drug: Ferric gluconate
RxNorm normalized name: Ferric Gluconate
DrugBank: Ferrous gluconate (DB14488)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferric gluconate 125 mg intravenously with eight consecutive hemodialysis sessions
Trial: 12143473
Drug: Optiflow dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optiflow dual lumen catheters at 350 ml/min
Trial: 12143473
Drug: Optiflow dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optiflow dual lumen catheters at 500 ml/min
Trial: 12143473
Drug: PermCath dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PermCath dual lumen catheters at 300 ml/min
Trial: 3294977
Drug: Azelastine 2
RxNorm normalized name: azelastine 2.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 2 mg
Trial: 7559264
Drug: Azelastine 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 4 mg
Trial: 3294977
Drug: Azelastine 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 8 mg
Trial: 3294977
Drug: Azelastine 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 12 mg
Trial: 3294977
Drug: Azelastine 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 16 mg
Trial: 30799375
Drug: Intracoronary darbepoetin‐α
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary darbepoetin‐α 300 μg
Trial: 23372114
Drug: Darunavir/ritonavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir/ritonavir monotherapy (DRV/r 800/100 mg once daily)
Trial: 27279571
Drug: Darunavir/ritonavir with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors (NRTIs)
Trial: 26460504
Drug: Darunavir/ritonavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir/ritonavir monotherapy (DRV/r)
Trial: 25988798
Drug: Standard-dose pentazocine/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose pentazocine/naloxone (50/0.5 mg)
Trial: 25988798
Drug: Low-dose pentazocine/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose pentazocine/naloxone (25/0.25 mg)
Trial: 23750517
Drug: NTC (No
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTC (No Treatment Control)
Trial: 10052484
Drug: Prednisolone (125-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (125-150 mg i.v.)
Trial: 7866820
Drug: OCM (omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OCM (omeprazole 20 mg once in the morning, clarithromycin 250 mg and metronidazole 400 mg twice daily)
Trial: 7866820
Drug: OCT (omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OCT (omeprazole 20 mg once in the morning, clarithromycin 250 mg and tetracycline 500 mg twice daily)
Trial: 31858823
Drug: Standard pelvic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pelvic floor muscle exercises and oscillating rod therapy
Trial: 31858823
Drug: Standard pelvic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pelvic floor muscle exercises and relaxation therapy
Trial: 22342864
Drug: Postinjury PUFAs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postinjury PUFAs (850 mg/d)
Trial: 12022301
Drug: Trophic feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trophic feeding (0.5‐1 ml h(‐1)) along with parenteral nutrition
Trial: 10526805
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion (0.07 +/- 0.03 microgram.kg‐1.min‐1) during desflurane-N2O anesthesia
Trial: 8770775
Drug: Subcutaneous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous low-dose interleukin-2 (IL-2) at doses of 1, 3, and 6 x 10(6) IU/day, administered once daily 6 days a week for 12 weeks.
Trial: 8770775
Drug: Subcutaneous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous low-dose interleukin-2 (IL-2) at doses of 1, 3, and 6 x 10(6) IU/day.
Trial: 1827543
Drug: GR32191 (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GR32191 (120 mg)
Trial: 6110040
Drug: Cimetidine therapy
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine therapy (full-dose and maintenance) with food
Trial: 22991015
Drug: Conventional PD
RxNorm normalized name: Dianeal PD-2/2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional PD solutions (Control)
Trial: 21030879
Drug: Lisinopril titrated
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril titrated to 80 mg daily and additional antihypertensives to target SBP < 130 mm Hg
Trial: 16943794
Drug: Tadalafil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil (20 mg) on alternate days (ADs) for 4 weeks
Trial: 16943794
Drug: Chronic tadalafil
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic tadalafil administration
Trial: 16943794
Drug: On-demand (OD)
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand (OD) tadalafil administration
Trial: 16258088
Drug: Intravenous unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous unfractionated heparin (continuous infusion of 100 U/kg per day)
Trial: 16258088
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (50 mL/day as a continuous infusion)
Trial: 1318081
Drug: 0.20 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.20 mg/kg diazepam
Trial: 1318081
Drug: 0.12 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12 mg/kg diazepam
Trial: 31741553
Drug: Intrathecal dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal dexamethasone (8 mg) and levobupivacaine (12.5 mg, 0.5%)
Trial: 31741553
Drug: Levobupivacaine (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (12.5 mg, 0.5%)
Trial: 29223101
Drug: Inhalation Anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation Anaesthesia (IA)
Trial: 27127650
Drug: Nasal high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high flow therapy at 37°C
Trial: 27127650
Drug: Nasal high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high flow therapy at 41°C
Trial: 27127650
Drug: Nasal high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high flow therapy at 37°C and 41°C
Trial: 16982936
Drug: Influenza vaccination
RxNorm normalized name: Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine Injection [PedvaxHIB]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccination (inactivated vaccine, administered intramuscularly)
Trial: 16982936
Drug: Influenza vaccination
RxNorm normalized name: Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine Injection [PedvaxHIB]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccination (live, attenuated vaccine, administered intranasally)
Trial: 14582335
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (SDXP/CQ)
Trial: 14582335
Drug: Late treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late treatment failure (asymptomatic)
Trial: 31935249
Drug: Body weight-adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body weight-adjusted dose of palonosetron (1 μg/kg, GI = 40 patients)
Trial: 31935249
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of palonosetron (75 μg, GII = 40 patients)
Trial: 31935249
Drug: Body weight-adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body weight-adjusted dose of palonosetron (1 μg/kg, GI)
Trial: 31935249
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of palonosetron (75 μg, GII)
Trial: 27398991
Drug: Walking shoes
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Walking shoes with triple‐density, variable‐stiffness midsoles and mild lateral‐wedge insoles worn daily
Trial: 20166156
Drug: Fractional CO(2)
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional CO(2) laser treatment
Trial: 20166156
Drug: Fractional Er:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional Er:YAG laser treatment
Trial: 15713002
Drug: Blood orange
RxNorm normalized name: ALCOHOL 70 mL in 100 mL TOPICAL SPRAY [All Clean Premium Hand Sanitizer Blood Orange]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood orange juice (600 mL/day)
Trial: 12969212
Drug: Prednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (1 mg/kg/day for 5 days) plus standard care
Trial: 8886750
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone 0.25 U/kg/week (subdivided in daily subcutaneous injections, starting with half the dosage for the first four weeks)
Trial: 8886750
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone 0.25 U/kg/week
Trial: 1352564
Drug: UW preservation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UW preservation solution
Trial: 6385759
Drug: Dose 1
RxNorm normalized name: Aldose 1-epimerase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 1 of ethyl alcohol resulting in a peak BAC of 100 mg/100 ml
Trial: 6385759
Drug: Dose 2
RxNorm normalized name: Fluzone High-Dose 2011-2012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 2 of ethyl alcohol administered when BAC had fallen to one-half the peak BAC from dose 1
Trial: 6385759
Drug: Placebo doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo doses administered to five brother-pairs (controls)
Trial: 30206728
Drug: Post-infusion scalp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-infusion scalp cooling for 90 minutes
Trial: 30206728
Drug: Post-infusion scalp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-infusion scalp cooling for 150 minutes
Trial: 25128520
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg weekly plus Methotrexate (MTX)
Trial: 22325110
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg norethindrone (NET)
Trial: 22325110
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg norethindrone (NET)
Trial: 16278523
Drug: Sustained-release verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release verapamil
Trial: 2171852
Drug: Oral amiloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amiloride 20 mg
Trial: 2171852
Drug: Inhaled amiloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled amiloride 10 ml of 10(‐2) mol/l
Trial: 9581
Drug: Chlorpromazine (C)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (C) 10 mg t.i.d. for 7 days, 20 mg t.i.d. for 7 days + Alcohol (A) 0.5 g/kg
Trial: 9581
Drug: Thioridazine (T)
RxNorm normalized name: Thioridazine
DrugBank: Thioridazine (DB00679)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thioridazine (T) 10 mg t.i.d. for 7 days, 20 mg t.i.d. for 7 days
Trial: 9581
Drug: Sulpiride (S)
RxNorm normalized name: sulpiride
DrugBank: Sulpiride (DB00391)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (S) 50 mg t.i.d. + Alcohol (A) 0.5 g/kg
Trial: 9581
Drug: Bromazepam (B)
DrugBank: Bromazepam (DB01558)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepam (B) 6 mg t.i.d. + Alcohol (A) 0.5 g/kg
Trial: 9581
Drug: Thioridazine (T)
RxNorm normalized name: Thioridazine
DrugBank: Thioridazine (DB00679)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thioridazine (T) + Alcohol (A) 0.5 g/kg
Trial: 9581
Drug: Chlorpromazine (C)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (C) + Alcohol (A) 0.5 g/kg
Trial: 9581
Drug: Sulpiride (S)
RxNorm normalized name: sulpiride
DrugBank: Sulpiride (DB00391)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (S) + Alcohol (A) 0.5 g/kg
Trial: 9581
Drug: Bromazepam (B)
DrugBank: Bromazepam (DB01558)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepam (B) + Alcohol (A) 0.5 g/kg
Trial: 18520336
Drug: Probiotics (Lactobacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (Lactobacillus GG, S. boulardii, L. reuteri)
Trial: 13678108
Drug: DentiPatch (lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DentiPatch (lidocaine patch)
Trial: 1597844
Drug: 4g of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4g of an oil preparation rich in C18:3n-6, C20:5n-3 and C22:6n-3
Trial: 6204153
Drug: Diuretics as
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide / reserpine Oral Tablet [Diuretic Ap-Es]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics as sole therapy
Trial: 6204153
Drug: Diuretics combined
RxNorm normalized name: atenolol and other diuretics, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics combined with alpha-methyldopa or propranolol
Trial: 26216382
Drug: Febuxostat (fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat (fixed dose 120 mg)
Trial: 26216382
Drug: Allopurinol (low/standard/high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (low/standard/high doses: 200/300/600 mg)
Trial: 24352085
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg allopurinol intravenously to the mother immediately prior to delivery
Trial: 15661234
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m², Carboplatin AUC 5, Gemcitabine 800 mg/m² on day 1 and Gemcitabine 800 mg/m² on day 8, every 3 weeks
Trial: 10468948
Drug: Hydrocortisone 15
RxNorm normalized name: hydrocortisone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 15 mg/day
Trial: 10468948
Drug: Hydrocortisone 20
RxNorm normalized name: hydrocortisone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 20 mg/day
Trial: 10468948
Drug: Hydrocortisone 30
RxNorm normalized name: hydrocortisone 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 30 mg/day
Trial: 1694831
Drug: Iloprost infusion
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost infusion (2-4 ng/kg/min for 12 hours daily on 5 consecutive days)
Trial: 21098802
Drug: 6-monthly screening
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 6-monthly screening
Trial: 21098802
Drug: 12-monthly screening
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 12-monthly screening
Trial: 18317624
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of midazolam and clonidine (40 microg/kg and 0.5 microg/kg respectively)
Trial: 18317624
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diazepam and clonidine (40 microg/kg and 0.5 microg/kg respectively)
Trial: 15774240
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with vinorelbine and estramustine phosphate plus ellagic acid (group B)
Trial: 15774240
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with vinorelbine and estramustine phosphate (group A)
Trial: 9865561
Drug: Cefuroxime (prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime (prophylactic dose)
Trial: 7034642
Drug: Amoxicillin plus
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin plus clavulanic acid
Trial: 2294131
Drug: Evening GH
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Evening GH injections (2000 h)
Trial: 2294131
Drug: Morning GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning GH injections (0800 h)
Trial: 368086
Drug: Pirprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirprofen (600 mg per day)
Trial: 368086
Drug: Aspirin (3600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (3600 mg per day)
Trial: 30052592
Drug: Medication-Assisted Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-Assisted Treatment (MAT)
Trial: 20457817
Drug: CXA-101 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CXA-101 (single doses of 250, 500, 1,000, 1,500, and 2,000 mg)
Trial: 20457817
Drug: CXA-101 (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CXA-101 (multiple doses of 500 mg every 8 h, 1,000 mg every 8 h, and 1,500 mg every 12 h for 10 days)
Trial: 20457817
Drug: CXA-101 (1-hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CXA-101 (1-hour infusion)
Trial: 12456849
Drug: Miltefosine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miltefosine (50 or 100 mg daily for 28 days)
Trial: 12456849
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (1 mg per kilogram every other day for a total of 15 injections)
Trial: 10350032
Drug: Pemoline (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemoline (3 mg/kg per day, mean dose 2.2 mg/kg per day)
Trial: 2401750
Drug: Maxzide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxzide (25 mg of hydrochlorothiazide and 37.5 mg of triamterene)
Trial: 2401750
Drug: Dyazide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dyazide (25 mg of hydrochlorothiazide and 50 mg of triamterene)
Trial: 453712
Drug: Fiberoptic bronchoscopy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiberoptic bronchoscopy followed by respiratory therapy for 48 hours
Trial: 453712
Drug: Respiratory therapy
RxNorm normalized name: respiratory therapy supplies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respiratory therapy alone for 48 hours
Trial: 31789006
Drug: Conventional hemostasis
RxNorm normalized name: collagen hemostat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional hemostasis (15 mL air injection)
Trial: 30910149
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (LDA), 1 capsule/day starting from the 21st day of the cycle prior to gonadotropin stimulation.
Trial: 30910149
Drug: Placebo, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 1 capsule/day starting from the 21st day of the cycle prior to gonadotropin stimulation.
Trial: 21334262
Drug: Glycerol (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol (75 mL four times a day for 4 days)
Trial: 21334262
Drug: Placebo (sugar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sugar solution equivalent volume)
Trial: 16886163
Drug: Single-dose lopinavir-ritonavir
RxNorm normalized name: lopinavir / ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose lopinavir-ritonavir
Trial: 27173369
Drug: Intravenous theophylline
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous theophylline (5 mg/kg)
Trial: 15237694
Drug: Matched intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched intravenous placebo
Trial: 8123409
Drug: Thiopentone 2
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone 2 mg kg‐1 + Suxamethonium 1 mg kg‐1